I agree with you about changing the medication. Since the drops they have given me which they've increased a week post surgery is not giving the desired results .I do believe and hope that there were other options. I'm hoping that's what the doctor this week who is my second opinion is going to come up with. It's 5 1/2 weeks post surgery and certainly worse than prior to the surgery . I Didn't wear any glasses before the Cataracs developed. I have what they call monovision. Since I had a retinal detachment in my right eye ( not the eye with the cataract removal)and that made the right eye good for reading without glasses the left eye which had the cataract surgery was for distance. Until the Cataracs got worse the distance was fine for driving and distance . the right I was fine for reading in essence again monovision. As I said the vision in the left eye I was 2030 prior to the cataract surgery. I was OK except for the effect of the cataracts.
At first, you might not notice that there’s anything wrong with your eyesight, which is why you may not be aware you have a cataract until it’s identified by an optician in your annual eye examination. However, as the cataract develops, your vision get worse, and it’s when your vision becomes severely affected that an operation is recommended. But you don’t always have to wait until that point to have cataract surgery, especially if you’re seeking private treatment for it or are heavily reliant on your eyes for your job (. driving).
Cost is another factor that must be weighed. Do the benefits of adding a steroid justify the added cost? My response is a resounding yes. Prednisolone acetate is available as a generic that costs between $10 and $25. Difluprednate ophthalmic emulsion (Durezol®, Alcon Laboratories, Inc.), a more potent benzylalkonium chloride (BAK)-free steroid emulsion, is $35 on average with the support of a manufacturer’s rebate, and also has improving Tier 2 coverage on many Medicare Part D plans. The NSAID I am using most now is nepafenac ophthalmic suspension % (Nevanac,), which has predominantly Tier 2 coverage costing about $40 per co-pay. I dose both of these medications in an off-label schedule (BID for two weeks, then decreasing the steroid to QD for two weeks while maintaining the NSAID at BID for an additional two weeks) and have had no adverse events and excellent inflammatory and pain control. One bottle of each will last the entire course of therapy and cost less than $100. In contrast, to prescribe a four-week course of Bromday would require two bottles, each of which are often more than $100. My patients are extremely pleased with the ease of BID dosing, and their postoperative outcomes have been outstanding.